235 related articles for article (PubMed ID: 28811579)
1. CXCL12 enhances angiogenesis through CXCR7 activation in human umbilical vein endothelial cells.
Zhang M; Qiu L; Zhang Y; Xu D; Zheng JC; Jiang L
Sci Rep; 2017 Aug; 7(1):8289. PubMed ID: 28811579
[TBL] [Abstract][Full Text] [Related]
2. CXCR7 Inhibits Fibrosis via Wnt/
Shen M; Feng Y; Wang J; Yuan Y; Yuan F
Biomed Res Int; 2020; 2020():1216926. PubMed ID: 32566651
[TBL] [Abstract][Full Text] [Related]
3. SDF1/CXCR7 Signaling Axis Participates in Angiogenesis in Degenerated Discs via the PI3K/AKT Pathway.
Zhang H; Wang P; Zhang X; Zhao W; Ren H; Hu Z
DNA Cell Biol; 2019 May; 38(5):457-467. PubMed ID: 30864829
[TBL] [Abstract][Full Text] [Related]
4. Chemokine receptor CXCR7 is a functional receptor for CXCL12 in brain endothelial cells.
Liu Y; Carson-Walter E; Walter KA
PLoS One; 2014; 9(8):e103938. PubMed ID: 25084358
[TBL] [Abstract][Full Text] [Related]
5. Pathogenic role of CXCR7 in rheumatoid arthritis.
Watanabe K; Penfold ME; Matsuda A; Ohyanagi N; Kaneko K; Miyabe Y; Matsumoto K; Schall TJ; Miyasaka N; Nanki T
Arthritis Rheum; 2010 Nov; 62(11):3211-20. PubMed ID: 20617529
[TBL] [Abstract][Full Text] [Related]
6. Chemokine receptor 7 targets the vascular endothelial growth factor via the AKT/ERK pathway to regulate angiogenesis in colon cancer.
Li X; Wang X; Li Z; Zhang Z; Zhang Y
Cancer Med; 2019 Sep; 8(11):5327-5340. PubMed ID: 31348616
[TBL] [Abstract][Full Text] [Related]
7. CXCR7 participates in CXCL12-induced CD34+ cell cycling through β-arrestin-dependent Akt activation.
Torossian F; Anginot A; Chabanon A; Clay D; Guerton B; Desterke C; Boutin L; Marullo S; Scott MG; Lataillade JJ; Le Bousse-Kerdilès MC
Blood; 2014 Jan; 123(2):191-202. PubMed ID: 24277075
[TBL] [Abstract][Full Text] [Related]
8. Expression and function of CXCL12/CXCR4/CXCR7 in thyroid cancer.
Zhu X; Bai Q; Lu Y; Lu Y; Zhu L; Zhou X; Wu L
Int J Oncol; 2016 Jun; 48(6):2321-9. PubMed ID: 27082011
[TBL] [Abstract][Full Text] [Related]
9. CXCR7 regulates breast tumor metastasis and angiogenesis in vivo and in vitro.
Qian T; Liu Y; Dong Y; Zhang L; Dong Y; Sun Y; Sun D
Mol Med Rep; 2018 Mar; 17(3):3633-3639. PubMed ID: 29257351
[TBL] [Abstract][Full Text] [Related]
10. CXCR7 mediated Giα independent activation of ERK and Akt promotes cell survival and chemotaxis in T cells.
Kumar R; Tripathi V; Ahmad M; Nath N; Mir RA; Chauhan SS; Luthra K
Cell Immunol; 2012; 272(2):230-41. PubMed ID: 22070874
[TBL] [Abstract][Full Text] [Related]
11. Naringin enhances endothelial progenitor cell (EPC) proliferation and tube formation capacity through the CXCL12/CXCR4/PI3K/Akt signaling pathway.
Zhao Z; Ma X; Ma J; Sun X; Li F; Lv J
Chem Biol Interact; 2018 Apr; 286():45-51. PubMed ID: 29510123
[TBL] [Abstract][Full Text] [Related]
12. The peptidomimetic CXCR4 antagonist TC14012 recruits beta-arrestin to CXCR7: roles of receptor domains.
Gravel S; Malouf C; Boulais PE; Berchiche YA; Oishi S; Fujii N; Leduc R; Sinnett D; Heveker N
J Biol Chem; 2010 Dec; 285(49):37939-43. PubMed ID: 20956518
[TBL] [Abstract][Full Text] [Related]
13. Atypical Chemokine Receptor 3 Generates Guidance Cues for CXCL12-Mediated Endothelial Cell Migration.
Tobia C; Chiodelli P; Barbieri A; Buraschi S; Ferrari E; Mitola S; Borsani G; Guerra J; Presta M
Front Immunol; 2019; 10():1092. PubMed ID: 31156639
[TBL] [Abstract][Full Text] [Related]
14. Inflammatory CXCL12-CXCR4/CXCR7 axis mediates G-protein signaling pathway to influence the invasion and migration of nasopharyngeal carcinoma cells.
Qiao N; Wang L; Wang T; Li H
Tumour Biol; 2016 Jun; 37(6):8169-79. PubMed ID: 26715277
[TBL] [Abstract][Full Text] [Related]
15. Biological/pathological functions of the CXCL12/CXCR4/CXCR7 axes in the pathogenesis of bladder cancer.
Nazari A; Khorramdelazad H; Hassanshahi G
Int J Clin Oncol; 2017 Dec; 22(6):991-1000. PubMed ID: 29022185
[TBL] [Abstract][Full Text] [Related]
16. Chemokine CXCL12 activates dual CXCR4 and CXCR7-mediated signaling pathways in pancreatic cancer cells.
Heinrich EL; Lee W; Lu J; Lowy AM; Kim J
J Transl Med; 2012 Apr; 10():68. PubMed ID: 22472349
[TBL] [Abstract][Full Text] [Related]
17. CXCL12-CXCR4/CXCR7 Axis in Colorectal Cancer: Therapeutic Target in Preclinical and Clinical Studies.
Khare T; Bissonnette M; Khare S
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298991
[TBL] [Abstract][Full Text] [Related]
18. Fibroblast-derived CXCL12/SDF-1α promotes CXCL6 secretion and co-operatively enhances metastatic potential through the PI3K/Akt/mTOR pathway in colon cancer.
Ma JC; Sun XW; Su H; Chen Q; Guo TK; Li Y; Chen XC; Guo J; Gong ZQ; Zhao XD; Qi JB
World J Gastroenterol; 2017 Jul; 23(28):5167-5178. PubMed ID: 28811711
[TBL] [Abstract][Full Text] [Related]
19. Crosstalk between SDF-1/CXCR4 and SDF-1/CXCR7 in cardiac stem cell migration.
Chen D; Xia Y; Zuo K; Wang Y; Zhang S; Kuang D; Duan Y; Zhao X; Wang G
Sci Rep; 2015 Nov; 5():16813. PubMed ID: 26578388
[TBL] [Abstract][Full Text] [Related]
20. CXCR7 agonists inhibit the function of CXCL12 by down-regulation of CXCR4.
Uto-Konomi A; McKibben B; Wirtz J; Sato Y; Takano A; Nanki T; Suzuki S
Biochem Biophys Res Commun; 2013 Feb; 431(4):772-6. PubMed ID: 23333329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
